시장보고서
상품코드
1087399

세계의 강박장애 치료제 시장(2022-2026년)

Global Obsessive-Compulsive Disorder Drugs Market 2022-2026

발행일: | 리서치사: TechNavio (Infiniti Research Ltd.) | 페이지 정보: 영문 120 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 강박장애 치료제 시장 규모는 2022-2026년간 2억 6,678만 달러의 증가가 전망되며, 예측기간 중 5.55%의 CAGR로 성장할 것으로 예측됩니다.

강박장애(OCD) 유병률 상승, 신규 분자약 발매, 강박장애(OCD)에 대한 계몽 활동이 시장을 견인하고 있습니다.

세계의 강박장애 치료제(Obsessive-Compulsive Disorder Drugs) 시장에 대해 조사 분석했으며, 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개사 벤더를 커버하는 벤더 분석을 제공합니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 상황

  • 시장 생태계

제3장 시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2021년)
  • 시장 전망 : 2021-2026년 예측

제4장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 협상력
  • 공급 기업의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제5장 제품별 시장 세분화

  • 시장 부문
  • 제품별 비교
  • SSRI : 시장 규모와 예측(2021-2026년)
  • TSA : 시장 규모와 예측(2021-2026년)
  • 기타 : 시장 규모와 예측(2021-2026년)
  • 제품별 시장 기회

제6장 고객 상황

  • 고객 상황 개요

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2021-2026년)
  • 유럽 : 시장 규모와 예측(2021-2026년)
  • 아시아 : 시장 규모와 예측(2021-2026년)
  • 기타 지역(ROW) : 시장 규모와 예측(2021-2026년)
  • 미국 : 시장 규모와 예측(2021-2026년)
  • 독일 : 시장 규모와 예측(2021-2026년)
  • 영국 : 시장 규모와 예측(2021-2026년)
  • 프랑스 : 시장 규모와 예측(2021-2026년)
  • 캐나다 : 시장 규모와 예측(2021-2026년)
  • 지역 상황별 시장 기회

제8장 성장 촉진요인, 과제, 동향

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 상황

  • 개요
  • 벤더 상황
  • 혼란 상황
  • 업계 위험

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • AbbVie Inc.
  • Apotex Inc.
  • Biohaven Pharmaceutical Holding Co. Ltd.
  • Dr. Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • H Lundbeck AS
  • Jazz Pharmaceuticals Plc
  • Novartis AG
  • Pfizer Inc.

제11장 부록

KSM 22.06.17

Technavio has been monitoring the obsessive-compulsive disorder drugs market and it is poised to grow by $ 266.78 mn during 2022-2026, accelerating at a CAGR of 5.55% during the forecast period. Our report on the obsessive-compulsive disorder drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of OCD, the launch of new molecules, and awareness programs for OCD.

The obsessive-compulsive disorder drugs market analysis includes product segment and geographic landscape.

Technavio's obsessive-compulsive disorder drugs market is segmented as below:

By Product

  • SSRI
  • TSA
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increased use of off-label therapies as one of the prime reasons driving the obsessive-compulsive disorder drugs market growth during the next few years. Also, expanding research on first-in-class peptide therapeutics and increasing generic approvals will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the obsessive-compulsive disorder drugs market covers the following areas:

  • Obsessive-compulsive disorder drugs market sizing
  • Obsessive-compulsive disorder drugs market forecast
  • Obsessive-compulsive disorder drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading obsessive-compulsive disorder drugs market vendors that include AbbVie Inc., Apotex Inc., Biohaven Pharmaceutical Holding Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, H Lundbeck AS, Jazz Pharmaceuticals Plc, Lannett Co. Inc., Lupin Ltd., Mallinckrodt Plc, Novartis AG, Omeros Corp., Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc. Also, the obsessive-compulsive disorder drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 SSRI - Market size and forecast 2021-2026
  • Exhibit 28: Chart on SSRI - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on SSRI - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on SSRI - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on SSRI - Year-over-year growth 2021-2026 (%)
  • 5.4 TSA - Market size and forecast 2021-2026
  • Exhibit 32: Chart on TSA - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on TSA - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on TSA - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on TSA - Year-over-year growth 2021-2026 (%)
  • 5.5 Others - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Product
  • Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 France - Market size and forecast 2021-2026
  • Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 89: AbbVie Inc. - Overview
  • Exhibit 90: AbbVie Inc. - Product / Service
  • Exhibit 91: AbbVie Inc. - Key offerings
  • 10.4 Apotex Inc.
  • Exhibit 92: Apotex Inc. - Overview
  • Exhibit 93: Apotex Inc. - Product / Service
  • Exhibit 94: Apotex Inc. - Key offerings
  • 10.5 Biohaven Pharmaceutical Holding Co. Ltd.
  • Exhibit 95: Biohaven Pharmaceutical Holding Co. Ltd. - Overview
  • Exhibit 96: Biohaven Pharmaceutical Holding Co. Ltd. - Product / Service
  • Exhibit 97: Biohaven Pharmaceutical Holding Co. Ltd. - Key offerings
  • 10.6 Dr. Reddys Laboratories Ltd.
  • Exhibit 98: Dr. Reddys Laboratories Ltd. - Overview
  • Exhibit 99: Dr. Reddys Laboratories Ltd. - Business segments
  • Exhibit 100: Dr. Reddys Laboratories Ltd. - Key offerings
  • Exhibit 101: Dr. Reddys Laboratories Ltd. - Segment focus
  • 10.7 Eli Lilly and Co.
  • Exhibit 102: Eli Lilly and Co. - Overview
  • Exhibit 103: Eli Lilly and Co. - Product / Service
  • Exhibit 104: Eli Lilly and Co. - Key offerings
  • 10.8 GlaxoSmithKline Plc
  • Exhibit 105: GlaxoSmithKline Plc - Overview
  • Exhibit 106: GlaxoSmithKline Plc - Business segments
  • Exhibit 107: GlaxoSmithKline Plc - Key news
  • Exhibit 108: GlaxoSmithKline Plc - Key offerings
  • Exhibit 109: GlaxoSmithKline Plc - Segment focus
  • 10.9 H Lundbeck AS
  • Exhibit 110: H Lundbeck AS - Overview
  • Exhibit 111: H Lundbeck AS - Product / Service
  • Exhibit 112: H Lundbeck AS - Key offerings
  • 10.10 Jazz Pharmaceuticals Plc
  • Exhibit 113: Jazz Pharmaceuticals Plc - Overview
  • Exhibit 114: Jazz Pharmaceuticals Plc - Product / Service
  • Exhibit 115: Jazz Pharmaceuticals Plc - Key news
  • Exhibit 116: Jazz Pharmaceuticals Plc - Key offerings
  • 10.11 Novartis AG
  • Exhibit 117: Novartis AG - Overview
  • Exhibit 118: Novartis AG - Business segments
  • Exhibit 119: Novartis AG - Key offerings
  • Exhibit 120: Novartis AG - Segment focus
  • 10.12 Pfizer Inc.
  • Exhibit 121: Pfizer Inc. - Overview
  • Exhibit 122: Pfizer Inc. - Product / Service
  • Exhibit 123: Pfizer Inc. - Key news
  • Exhibit 124: Pfizer Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 125: Inclusions checklist
  • Exhibit 126: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 127: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 128: Research methodology
  • Exhibit 129: Validation techniques employed for market sizing
  • Exhibit 130: Information sources
  • 11.5 List of abbreviations
  • Exhibit 131: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제